Nemonoxacin: Quinolone antibiotic

Drugs of the Future

Volumn 34, Issue 3, 2009, Pages 196-203

  Arjona, A ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; GEMIFLOXACIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; NEMONOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TG 873870; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; CONTACT DERMATITIS; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHEMA; HEADACHE; HUMAN; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOTOTOXICITY; PRURITUS; RASH; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 76349114472     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.03.1350294     Document Type: Review

References (25)

1. Reilly, M. (The Procter & Gamble Co.). A coupling process for preparing quinolone intermediates. CA 2647454, EP1999125, US 2007232804, US 7456279, WO 2007110835.
2. Hayes, M.P., Schunk, T.T. (The Procter & Gamble Co.). A hydride reduction process for preparing quinolone intermediates. CA 2647457, EP1999106, US 2007232806, WO 2007110836.
3. Ledoussal, B., Hu, X.E., Gray, J.L., Almstead, J.-I.K. (The Procter & Gamble Co.). Antimicrobial quinolones, their compositions and uses. CA 2303389, EP 1015445, JP 2001516756, US 6329391, US 6387928, WO 1999014214.
4. Andriole, V.T. The quinolones: Past, present, and future. Clin Infect Dis 2005, 41(Suppl. 2): S113-9.
5. Zhao, X., Xu, C., Domagala, J., Drlica, K. DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance. Proc Natl Acad Sci USA 1997,94(25):13991-6.
6. Andriole, V.T. Are all quinolones created equal? Mediguide to Infectious Diseases 2001,1-5.
7. Low, D.E. Quinolone resistance among pneumococci: Therapeutic and diagnostic implications. Clin Infect Dis 2004, 38(Suppl. 4): S357-62.
8. Zhanel, G.G., Laing, N., Decorby, M. et at. Activity of nemonoxacin, an investigational C8-methoxy non-fluorinated quinolone against Gram-positive COCCI obtained from Canadian hospitals: CANWARD 2007. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, DC.) 2008, Abst F1-2057.
9. Laing, N., Decorby, M., Nichol, K. et al. Activity of nemonoxacin, an investigational C8-methoxy non-fluorinated quinolone, against Gram-negative bacilli obtained from Canadian Hospitals: CANWARD 2007. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, DC.) 2008, Abst C1-1957.
10. Hsueh, P., Yang, J., King, C. In vitro activity of nemonoxacin against Helicobacter pylori. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst C2-3931.
11. Hsueh, P., King, C. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Streptococcus pneumoniae in Taiwan. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst C2-254.
12. Pankuch, G.A., Kosowska-Shick, K., King, C.R., Appelbaum, P.C. Comparative ontistaphylococcal activity of nemonoxacin, a novel broad-spectrum quinolone. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst C1-189.
13. Lauderdale, T.L., Shiau, YR., Lai, J.F., Chen, H.C., King, C.H.R. In vitro antibacterial activity of nemonoxacin (TG-873870), a new non-fluorinated quinolone, against clinical isolates. 47th lntersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 17-20, Chicago) 2007, Abst E-1635.
14. Hsu, C.H., Lin, L., Leunk, R., Reichart, D. In vivo efficacy of nemonoxacin in a mouse protection model. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst B-1005.
15. Hsu, C.H., Lin, L., Leunk, R., Reichart, D. In vivo efficacy of nemonoxacin in a mouse pulmonary infection model. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst B-056.
16. Zhang, H., Chiu, K.M., Chung, T.K., Tan, H.C., Lin, L. Multiple-dose study to access the safety, tolerability and pharmacokinetics of nemonoxacin (TG-873870) in healthy volunteers. 45th Annu Meet Infect Dis Soc Am (IDSA) (Oct 4-7, San Diego) 2007, Abst 440.
17. Chen, S.J., Lin, L., Chang, L.W. Analysis of anti-bacterial response of nemonoxacin (TG-873870) against major pathogens from respiratory tract and skin infections. 45th Annu Meet Infect Dis Soc Am (IDSA) (Oct 4-7, San Diego) 2007, Abst 441.
18. Lin, L., Chiu, K.M., Chung, T.K. Single-dose safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum non-fluorinated quinolone, in healthy volunteers. 45th Annu Meet Infect Dis Soc Am (IDSA) (Oct 4-7, San Diego) 2007, Abst 439.
19. Chow, C.R., Tsai, C.Y., Yeh, C.F., Chen, S.J. In vitro metabolism and interaction of nemonoxacin (TG-873870) on human hepatic CYP3A4. 47th lntersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 17-20, Chicago) 2007, Abst A-27.
20. Hsu, C.H., Chen, YM., Chow, C.P. Fertility and early embryonic developmental toxicity of nemonoxacin after oral administration to rats. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst F1-2056.
21. Hsu, C.H., Chen, Y.M., Chow, C.P. Systemic hypersensitivity test of nemonoxacin, a novel potent broad-spectrum non-fluorinated quinolone, in guinea pigs. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst F1-2055.
22. Chow, C.P., Tsai, C.Y., Chen, Y.M. Cardiovascular safety evaluation of nemonoxacin (TG-873870) in dogs and monkeys. 47th lntersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 17-20, Chicago) 2007, Abst B-823.
23. Chow, C.P., Sambuco, C. Phototoxicity of nemonoxacin (TG-873870) in hairless mice. 47th lntersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 17-20, Chicago) 2007, Abst A-28.
24. Van Rensburg, D.J., Perng, R.P., Lin, L., Zhang, H. Efficacy and safety of nemonoxacin versus levofloxacin for the treatment of community-acquired pneumonia. 48th Annu lntersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst L-678.
25. Safety and efficacy study of TG-873870 (nemonoxacin) in diabetic foot infections (NCT00685698). ClinicalTrials.gov Web site, March 29,2009.